Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hanbyoul Cho

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Cancers

International journal of molecular sciences

PLoS pathogens

Journal of cellular and molecular medicine

Yonsei University College of Medicine

Yonsei University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yonsei University College of Medicine Mar 1o 2015

South Korea

Associate Professor :: Obstetrics and Gynecology

Education History

Yonsei University

South Korea

PHD

Publications

Jung-A Choi, Elizabeth Hyeji Lee, Hanbyoul Cho, Jae-Hoon Kim
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Jung-A Choi, Elizabeth Hyeji Lee, Hanbyoul Cho, Jae-Hoon Kim
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Ha Kyun Chang, Young Hoon Park, Jung-A Choi, Jeong Won Kim, Jisup Kim, Hyo Sun Kim, Hae Nam Lee, Hanbyoul Cho, Joon-Yong Chung, Jae-Hoon Kim
Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment. Cancers 15 (10) (2023)
Jung-A Choi, Elizabeth Hyeji Lee, Hanbyoul Cho, Jae-Hoon Kim
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Ha-Yeon Shin, Eun-Ju Lee, Wookyeom Yang, Hyo Sun Kim, Dawn Chung, Hanbyoul Cho, Jae-Hoon Kim
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models. Cancers 14 (3) (2022)
Gwan Hee Han, Jung Eun Shim, Hee Yun, Julie Kim, Jae-Hoon Kim, Hanbyoul Cho
RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer. The journal of gene medicine 24 (11) (2022)
Gwan Hee Han, Hee Yun, Joon-Yong Chung, Jae-Hoon Kim, Hanbyoul Cho
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis. Cancer genomics & proteomics 19 (6) (2022)
Hee Yun, Gwan Hee Han, Julie Kim, Joon-Yong Chung, Jae-Hoon Kim, Hanbyoul Cho
NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells. Journal of cellular and molecular medicine 26 (20) (2022)
Gwan Hee Han, Ilseon Hwang, Hanbyoul Cho, Kris Ylaya, Jung-A Choi, Hyunja Kwon, Joon-Yong Chung, Stephen M Hewitt, Jae-Hoon Kim
Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer. International journal of molecular sciences 22 (11) (2021)
Adrian J Luna, Rosa T Sterk, Anastacia M Griego-Fisher, Joon-Yong Chung, Kiersten L Berggren, Virginie Bondu, Pamela Barraza-Flores, Andrew T Cowan, Gregory N Gan, Emrullah Yilmaz, Hanbyoul Cho, Jae-Hoon Kim, Stephen M Hewitt, Julie E Bauman, Michelle A Ozbun
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors. PLoS pathogens 17 (1) (2021)
Wookyeom Yang, Ha-Yeon Shin, Hanbyoul Cho, Joon-Yong Chung, Eun-Ju Lee, Jae-Hoon Kim, Eun Suk Kang
TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels. Cancers 12 (5) (2020)
Doo Byung Chay, Gwan Hee Han, Sanghee Nam, Hanbyoul Cho, Joon-Yong Chung, Stephen M Hewitt
Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer. International journal of clinical oncology 24 (11) (2019)
Jung-A Choi, Hyunja Kwon, Hanbyoul Cho, Joon-Yong Chung, Stephen M Hewitt, Jae-Hoon Kim
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer. Cancers 11 (10) (2019)
Gwan Hee Han, Doo Byung Chay, Sanghee Nam, Hanbyoul Cho, Joon-Yong Chung, Jae-Hoon Kim
Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer. BMC cancer 19 (1) (2019)

Hanbyoul Cho.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hanbyoul Cho